sacituzumab govitecan
gilead sciences
[' sg ', 'breast', 'tropics02']
largely awaited results of #tropics02 trial presented by at #asco22 showing pfs benefit for sacituzumab over chemotherapy in pre-treated hr+ metastatic breast cancer os data still pending favourable qol for sg 25% primary resistance in the first 3 months 
M.D. - Research Fellow @MSKCancerCenter | Former Medical Oncology Fellow @LaStatale @IEOufficiale | Interested in #genomics #bioinformatics #AI #bcsm #newdrugs